Literature DB >> 21310726

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Tracy R Melzer1, Richard Watts, Michael R MacAskill, John F Pearson, Sina Rüeger, Toni L Pitcher, Leslie Livingston, Charlotte Graham, Ross Keenan, Ajit Shankaranarayanan, David C Alsop, John C Dalrymple-Alford, Tim J Anderson.   

Abstract

There is a need for objective imaging markers of Parkinson's disease status and progression. Positron emission tomography and single photon emission computed tomography studies have suggested patterns of abnormal cerebral perfusion in Parkinson's disease as potential functional biomarkers. This study aimed to identify an arterial spin labelling magnetic resonance-derived perfusion network as an accessible, non-invasive alternative. We used pseudo-continuous arterial spin labelling to measure cerebral grey matter perfusion in 61 subjects with Parkinson's disease with a range of motor and cognitive impairment, including patients with dementia and 29 age- and sex-matched controls. Principal component analysis was used to derive a Parkinson's disease-related perfusion network via logistic regression. Region of interest analysis of absolute perfusion values revealed that the Parkinson's disease pattern was characterized by decreased perfusion in posterior parieto-occipital cortex, precuneus and cuneus, and middle frontal gyri compared with healthy controls. Perfusion was preserved in globus pallidus, putamen, anterior cingulate and post- and pre-central gyri. Both motor and cognitive statuses were significant factors related to network score. A network approach, supported by arterial spin labelling-derived absolute perfusion values may provide a readily accessible neuroimaging method to characterize and track progression of both motor and cognitive status in Parkinson's disease.

Entities:  

Mesh:

Year:  2011        PMID: 21310726      PMCID: PMC3105489          DOI: 10.1093/brain/awq377

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  48 in total

Review 1.  Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults.

Authors:  P C Buijs; M J Krabbe-Hartkamp; C J Bakker; E E de Lange; L M Ramos; M M Breteler; W P Mali
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

2.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

Authors:  T Vander Borght; S Minoshima; B Giordani; N L Foster; K A Frey; S Berent; R L Albin; R A Koeppe; D E Kuhl
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

3.  Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging.

Authors:  Shuhei Kasama; Hisao Tachibana; Keita Kawabata; Hiroo Yoshikawa
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-18       Impact factor: 2.959

4.  Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

Authors:  G Berding; P Odin; D J Brooks; G Nikkhah; C Matthies; T Peschel; M Shing; H Kolbe; J van Den Hoff; H Fricke; R Dengler; M Samii; W H Knapp
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Authors:  D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

7.  Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.

Authors:  Yasunori Mito; Kazuto Yoshida; Ichiro Yabe; Kenichi Makino; Makoto Hirotani; Kunio Tashiro; Seiji Kikuchi; Hidenao Sasaki
Journal:  Clin Neurol Neurosurg       Date:  2005-01-19       Impact factor: 1.876

8.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

Review 10.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

View more
  77 in total

1.  Accuracy of Parenchymal Cerebral Blood Flow Measurements Using Pseudocontinuous Arterial Spin-Labeling in Healthy Volunteers.

Authors:  K Ambarki; A Wåhlin; L Zarrinkoob; R Wirestam; J Petr; J Malm; A Eklund
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

2.  Functional neuroimaging of motor control in Parkinson's disease: a meta-analysis.

Authors:  Damian M Herz; Simon B Eickhoff; Annemette Løkkegaard; Hartwig R Siebner
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

4.  Parkinson's disease-related spatial covariance pattern identified with resting-state functional MRI.

Authors:  Tao Wu; Yilong Ma; Zheng Zheng; Shichun Peng; Xiaoli Wu; David Eidelberg; Piu Chan
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

5.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

6.  Template-based approach for detecting motor task activation-related hyperperfusion in pulsed ASL data.

Authors:  Jan Petr; Jean-Christophe Ferré; Hélène Raoult; Elise Bannier; Jean-Yves Gauvrit; Christian Barillot
Journal:  Hum Brain Mapp       Date:  2013-02-13       Impact factor: 5.038

Review 7.  Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease.

Authors:  Shichun Peng; David Eidelberg; Yilong Ma
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

8.  Spatially adaptive unsupervised multispectral nonlocal filtering for improved cerebral blood flow mapping using arterial spin labeling magnetic resonance imaging.

Authors:  Mustapha Bouhrara; Diana Y Lee; Abinand C Rejimon; Christopher M Bergeron; Richard G Spencer
Journal:  J Neurosci Methods       Date:  2018-08-18       Impact factor: 2.390

9.  Differentiating Patients with Parkinson's Disease from Normal Controls Using Gray Matter in the Cerebellum.

Authors:  Ling-Li Zeng; Liang Xie; Hui Shen; Zhiguo Luo; Peng Fang; Yanan Hou; Beisha Tang; Tao Wu; Dewen Hu
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

10.  Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Authors:  Shichun Peng; Yilong Ma; Phoebe G Spetsieris; Paul Mattis; Andrew Feigin; Vijay Dhawan; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.